Drug intelligence / Profile preview

CC-2004772

Development stage: Unknown
Administration: Oral

Overview

CC-2004772 is an investigational drug whose pharmacokinetics and clinical characteristics are referenced as a measurable analyte in clinical trial NCT04951778. The drug is administered orally, indicating it is being evaluated for its absorption, distribution, metabolism, and excretion in the context of clinical research. No information about molecular structure, mechanism of action, therapeutic class, or indication is available from the provided sources.

Beyond the preview

Go deeper on CC-2004772.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CC-2004772.

Explore the full profile